N. Potter

发表

N. Potter, 2002 .

Presentation of a T Cell Receptor Antagonist Peptide by Immunoglobulins Ablates Activation of T Cells by a Synthetic Peptide or Proteins Requiring Endocytic Processing

K. Legge, B. Min, H. Zaghouani, 1997, The Journal of experimental medicine.

Detection of trinucleotide repeat containing genes by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry.

Chung-Hsuan Chen, N. Potter, Nelly T Taranenko, 2003, Methods in molecular biology.

Uptake of a colorectal cancer screening blood test is higher than of a fecal test offered in clinic: A randomized trial

T. deVos, N. Perrin, G. Coronado, 2017 .

Colorectal Cancer Screening Recommendations.

K. Mergener, L. Perdue, Maryam Doroudi, 2016, JAMA.

Genetic Testing for Ataxia in North America

M. Nance, N. Potter, 2000, Molecular Diagnosis.

Genetic testing for ataxia in North America.

M. Nance, N. Potter, 2000 .

Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7.

M. Patterson, C. Gomez, M. Nance, 2002, American journal of medical genetics.

Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein.

P. Bigazzi, N. Potter, 1992, Investigative ophthalmology & visual science.

Issues & opinion. Sporadic ALS and chromosome 22: Evidence for a possible neurofilament gene defect

M. Meyer, N. Potter, 1995 .

Humoral immune recognition of proteolipid protein (PLP)‐specific encephalitogenic epitopes in the SJL/J mouse

N. Potter, T. S. Stephens, 1994, Journal of neuroscience research.

Therelationship between(CAG) repeat numberandage ofonsetina family with dentatorubral-pa llidoluysian atrophy (DRPLA): diagnostic implications ofconfirmatory and predictive testing

N. Potter, 1996 .

Identification and characterization of a B‐cell determinant within the amphipathic domain (residues 178–238) of the myelin proteolipid protein

M. Pákáski, M. Lees, N. Potter, 1996, Journal of neuroscience research.

Identification of an antigenic determinant within the phylogenetically conserved triprolyl region of myelin basic protein.

G. Hashim, E. Day, N. Potter, 1986, Journal of immunology.

Standards and Recommendations for Molecular Diagnostic Testing for Huntington Disease, the Autosomal Dominant Spinocerebellar Ataxias, and Friedreich Ataxia

N. Potter, 2010 .

Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia.

J. Vincent, T. Ashizawa, M. Pandolfo, 2004, American journal of human genetics.

Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study

D. Johnson, K. Mergener, R. Barclay, 2014, PloS one.

Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.

P. Hurban, C. Lofton-Day, Mary N. White, 2014, Clinical chemistry.

Polyclonal antibodies to the encephalitogenic neighborhoods of myelin basic protein: Singular affinity populations neutralized by specific synthetic peptide probes

G. Hashim, E. Day, N. Potter, 1986, Journal of Neuroimmunology.

Immunochemical analysis of Lewis rat antisera to the synthetic encephalitogenic peptide S49

G. Hashim, E. Day, N. Potter, 1985, Neurochemical Research.

Technical Standards and Guidelines for Huntington Disease Testing

T. Prior, E. Spector, N. Potter, 2004, Genetics in Medicine.

A unique origin and multistep process for the generation of expanded DRPLA triplet repeats.

I. Kanazawa, T. Miyashita, Koichiro Nakamura, 1996, Human molecular genetics.

Meiotic instability associated with the CAGR1 trinucleotide repeat at 13q13.

N. Potter, 1997, Journal of medical genetics.

Laboratory Guidelines for Huntington Disease Genetic Testing

Robin L. Bennett, Richard H. Myers, Nicholas T. Potter, 1998 .

B-Cell Lymphoma With Intermediate- to High- Grade Features and Different Immunophenotypic Profiles Involving Separate Anatomic Sites With a Good Response to R-CHOP

D. Henley, C. Ramsey, M. C. Phelan, 2009 .

BCL7B (B-cell CLL/lymphoma 7B)

N. Potter, 2011 .

Expression and distribution of the dentatorubral-pallidoluysian atrophy gene product (atrophin-1/drplap) in neuronal and non-neuronal tissues

S. Knight, A. Osmand, N. Potter, 1997, Journal of the Neurological Sciences.

A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease–like 2

C. Ross, A. Brice, G. Stevanin, 2001, Nature Genetics.

Immunochemical characterization of antibodies to the myelin proteolipid protein (PLP)

M. Lees, N. Potter, 1988, Journal of Neuroimmunology.

Huntington's disease–like 2 (HDL2) in North America and Japan

J. Mysore, M. MacDonald, M. Hayden, 2004, Annals of neurology.

Relationships among cytokines (IL-1, TNF, and IL-8) and histologic markers of acute ascending intrauterine infection

C. Homon, A. Vintzileos, C. Salafia, 1992 .

Monoclonal and polyclonal antibodies to myelin basic protein determinants

E. Day, N. Potter, 1986, Journal of Neuroimmunology.

Rate of detection of high-risk HPV with two assays in women ≥ 30 years of age.

M. Chivukula, N. Quigley, N. Potter, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Immunochemical specificity of antisera raised against the synthetic encephalitogenic peptide SH624, residues 59–74 of the myelin basic protein

G. Hashim, E. Day, N. Potter, 2004, Neurochemical Research.

A major epitope of synthetic rabbit encephalitogen S24 disclosed through the use of a tritiated peptide probe

G. Hashim, E. Day, N. Potter, 1987, Journal of neuroscience research.

Epibodies in autoimmunity: antisera against autoantibodies to the renal glomerular basement membrane react with idiotypes as well as with autoantigens.

P. Bigazzi, J. Michaelson, N. Potter, 1989, Autoimmunity.

Unstable expansion of the CAG trinucleotide repeat in MAB21L1: report of a second pedigree and effect on protein expression

C. Ross, A. Rosenblatt, R. Margolis, 1999, Journal of medical genetics.

Spinocerebellar Ataxia Type 8: Molecular Genetic Comparisons and Haplotype Analysis of 37 Families with Ataxia

J. Vincent, T. Ashizawa, M. Pandolfo, 2022 .

Mutation detection in an equivocal case of Friedreich's ataxia.

C. Miller, N. Potter, I. Anderson, 2000, Pediatric neurology.

Different origins of expanded repeats for Haw River syndrome and dentatorubralpallidoluysian atrophy

M. Yamada, H. Yanagisawa, N. Potter, 1996, The Lancet.

Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia.

J. Vincent, T. Ashizawa, M. Pandolfo, 2004, American journal of human genetics.

Presentation of a T Cell Receptor Antagonist Peptide by Immunoglobulins Ablates Activation of T Cells by a Synthetic Peptide or Proteins Requiring Endocytic Processing

K. Legge, B. Min, H. Zaghouani, 1997, The Journal of experimental medicine.

Molecular and clinical findings in a family with dentatorubral‐pallidoluysian atrophy

M. Meyer, A. Zimmerman, N. Potter, 1995, Annals of neurology.

You can build it ... but will they come?: the potential "expansion" of testing methodologies for fragile X syndrome.

N. Potter, 2009, The Journal of molecular diagnostics : JMD.